American Century Companies’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.1M | Buy |
1,757,988
+1,231,419
| +234% | +$26.7M | 0.02% | 790 |
|
|
2025
Q1 | $12.8M | Buy |
526,569
+369,160
| +235% | +$8.95M | 0.01% | 1231 |
|
|
2024
Q4 | $3.29M | Buy |
157,409
+24,395
| +18% | +$509K | ﹤0.01% | 1792 |
|
|
2024
Q3 | $2.64M | Sell |
133,014
-37,171
| -22% | -$739K | ﹤0.01% | 1850 |
|
|
2024
Q2 | $2.64M | Sell |
170,185
-94,950
| -36% | -$1.47M | ﹤0.01% | 1788 |
|
|
2024
Q1 | $4.23M | Sell |
265,135
-652,443
| -71% | -$10.4M | ﹤0.01% | 1522 |
|
|
2023
Q4 | $15.4M | Buy |
917,578
+18,100
| +2% | +$304K | 0.01% | 968 |
|
|
2023
Q3 | $10.5M | Buy |
899,478
+153,697
| +21% | +$1.8M | 0.01% | 1049 |
|
|
2023
Q2 | $10M | Sell |
745,781
-66,425
| -8% | -$893K | 0.01% | 1051 |
|
|
2023
Q1 | $13.5M | Sell |
812,206
-28,095
| -3% | -$466K | 0.01% | 900 |
|
|
2022
Q4 | $15.6M | Buy |
840,301
+80,127
| +11% | +$1.49M | 0.01% | 807 |
|
|
2022
Q3 | $9.75M | Buy |
760,174
+128,270
| +20% | +$1.65M | 0.01% | 904 |
|
|
2022
Q2 | $4.43M | Buy |
631,904
+286,556
| +83% | +$2.01M | ﹤0.01% | 1149 |
|
|
2022
Q1 | $2.86M | Buy |
345,348
+124,924
| +57% | +$1.04M | ﹤0.01% | 1293 |
|
|
2021
Q4 | $1.49M | Buy |
220,424
+53,383
| +32% | +$361K | ﹤0.01% | 1480 |
|
|
2021
Q3 | $885K | Buy |
167,041
+81,497
| +95% | +$432K | ﹤0.01% | 1650 |
|
|
2021
Q2 | $492K | Buy |
85,544
+43,114
| +102% | +$248K | ﹤0.01% | 1846 |
|
|
2021
Q1 | $196K | Buy |
42,430
+5,031
| +13% | +$23.2K | ﹤0.01% | 2089 |
|
|
2020
Q4 | $125K | Buy |
37,399
+2,533
| +7% | +$8.47K | ﹤0.01% | 1918 |
|
|
2020
Q3 | $104K | Buy |
34,866
+16,119
| +86% | +$48.1K | ﹤0.01% | 1759 |
|
|
2020
Q2 | $87K | Buy |
+18,747
| New | +$87K | ﹤0.01% | 1674 |
|